Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata

Abstract The echinocandins are relatively new antifungal drugs that represent, together with the older azoles, the recommended and/or preferred agents to treat candidaemia and other forms of invasive candidiasis in human patients. If “time is of the essence” to reduce the mortality for these infecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Antonietta Vella, Elena De Carolis, Enrica Mello, David S. Perlin, Dominique Sanglard, Maurizio Sanguinetti, Brunella Posteraro
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3374dd3f93e546dcbf3a5f20ef61d98d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3374dd3f93e546dcbf3a5f20ef61d98d
record_format dspace
spelling oai:doaj.org-article:3374dd3f93e546dcbf3a5f20ef61d98d2021-12-02T11:52:56ZPotential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata10.1038/s41598-017-09329-42045-2322https://doaj.org/article/3374dd3f93e546dcbf3a5f20ef61d98d2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09329-4https://doaj.org/toc/2045-2322Abstract The echinocandins are relatively new antifungal drugs that represent, together with the older azoles, the recommended and/or preferred agents to treat candidaemia and other forms of invasive candidiasis in human patients. If “time is of the essence” to reduce the mortality for these infections, the administration of appropriate antifungal therapy could be accelerated by the timely reporting of laboratory test results. In this study, we attempted to validate a MALDI-ToF mass spectrometry-based assay for the antifungal susceptibility testing (AFST) of the potentially multidrug-resistant pathogen Candida glabrata against anidulafungin and fluconazole. The practical applicability of the assay, reported here as MS-AFST, was assessed with a panel of clinical isolates that were selected to represent phenotypically and genotypically/molecularly susceptible or resistant strains. The data show the potential of our assay for rapid detection of antifungal resistance, although the MS-AFST assay performed at 3 h of the in vitro antifungal exposure failed to detect C. glabrata isolates with echinocandin resistance-associated FKS2 mutations. However, cell growth kinetics in the presence of anidulafungin revealed important cues about the in vitro fitness of C. glabrata isolates, which may lead to genotypic or phenotypic antifungal testing in clinical practice.Antonietta VellaElena De CarolisEnrica MelloDavid S. PerlinDominique SanglardMaurizio SanguinettiBrunella PosteraroNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Antonietta Vella
Elena De Carolis
Enrica Mello
David S. Perlin
Dominique Sanglard
Maurizio Sanguinetti
Brunella Posteraro
Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata
description Abstract The echinocandins are relatively new antifungal drugs that represent, together with the older azoles, the recommended and/or preferred agents to treat candidaemia and other forms of invasive candidiasis in human patients. If “time is of the essence” to reduce the mortality for these infections, the administration of appropriate antifungal therapy could be accelerated by the timely reporting of laboratory test results. In this study, we attempted to validate a MALDI-ToF mass spectrometry-based assay for the antifungal susceptibility testing (AFST) of the potentially multidrug-resistant pathogen Candida glabrata against anidulafungin and fluconazole. The practical applicability of the assay, reported here as MS-AFST, was assessed with a panel of clinical isolates that were selected to represent phenotypically and genotypically/molecularly susceptible or resistant strains. The data show the potential of our assay for rapid detection of antifungal resistance, although the MS-AFST assay performed at 3 h of the in vitro antifungal exposure failed to detect C. glabrata isolates with echinocandin resistance-associated FKS2 mutations. However, cell growth kinetics in the presence of anidulafungin revealed important cues about the in vitro fitness of C. glabrata isolates, which may lead to genotypic or phenotypic antifungal testing in clinical practice.
format article
author Antonietta Vella
Elena De Carolis
Enrica Mello
David S. Perlin
Dominique Sanglard
Maurizio Sanguinetti
Brunella Posteraro
author_facet Antonietta Vella
Elena De Carolis
Enrica Mello
David S. Perlin
Dominique Sanglard
Maurizio Sanguinetti
Brunella Posteraro
author_sort Antonietta Vella
title Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata
title_short Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata
title_full Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata
title_fullStr Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata
title_full_unstemmed Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata
title_sort potential use of maldi-tof mass spectrometry for rapid detection of antifungal resistance in the human pathogen candida glabrata
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3374dd3f93e546dcbf3a5f20ef61d98d
work_keys_str_mv AT antoniettavella potentialuseofmalditofmassspectrometryforrapiddetectionofantifungalresistanceinthehumanpathogencandidaglabrata
AT elenadecarolis potentialuseofmalditofmassspectrometryforrapiddetectionofantifungalresistanceinthehumanpathogencandidaglabrata
AT enricamello potentialuseofmalditofmassspectrometryforrapiddetectionofantifungalresistanceinthehumanpathogencandidaglabrata
AT davidsperlin potentialuseofmalditofmassspectrometryforrapiddetectionofantifungalresistanceinthehumanpathogencandidaglabrata
AT dominiquesanglard potentialuseofmalditofmassspectrometryforrapiddetectionofantifungalresistanceinthehumanpathogencandidaglabrata
AT mauriziosanguinetti potentialuseofmalditofmassspectrometryforrapiddetectionofantifungalresistanceinthehumanpathogencandidaglabrata
AT brunellaposteraro potentialuseofmalditofmassspectrometryforrapiddetectionofantifungalresistanceinthehumanpathogencandidaglabrata
_version_ 1718394916538679296